1. Home
  2. APYX vs LPCN Comparison

APYX vs LPCN Comparison

Compare APYX & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • LPCN
  • Stock Information
  • Founded
  • APYX 1982
  • LPCN 1997
  • Country
  • APYX United States
  • LPCN United States
  • Employees
  • APYX N/A
  • LPCN N/A
  • Industry
  • APYX Medical/Dental Instruments
  • LPCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • APYX Health Care
  • LPCN Health Care
  • Exchange
  • APYX Nasdaq
  • LPCN Nasdaq
  • Market Cap
  • APYX 42.3M
  • LPCN 36.8M
  • IPO Year
  • APYX 1987
  • LPCN N/A
  • Fundamental
  • Price
  • APYX $1.29
  • LPCN $5.23
  • Analyst Decision
  • APYX Hold
  • LPCN Strong Buy
  • Analyst Count
  • APYX 2
  • LPCN 1
  • Target Price
  • APYX N/A
  • LPCN $10.00
  • AVG Volume (30 Days)
  • APYX 59.9K
  • LPCN 30.9K
  • Earning Date
  • APYX 11-08-2024
  • LPCN 11-07-2024
  • Dividend Yield
  • APYX N/A
  • LPCN N/A
  • EPS Growth
  • APYX N/A
  • LPCN N/A
  • EPS
  • APYX N/A
  • LPCN N/A
  • Revenue
  • APYX $48,542,000.00
  • LPCN $7,922,926.00
  • Revenue This Year
  • APYX N/A
  • LPCN N/A
  • Revenue Next Year
  • APYX $6.46
  • LPCN N/A
  • P/E Ratio
  • APYX N/A
  • LPCN N/A
  • Revenue Growth
  • APYX N/A
  • LPCN N/A
  • 52 Week Low
  • APYX $0.97
  • LPCN $2.38
  • 52 Week High
  • APYX $3.26
  • LPCN $11.79
  • Technical
  • Relative Strength Index (RSI)
  • APYX 56.25
  • LPCN 48.49
  • Support Level
  • APYX $1.11
  • LPCN $4.79
  • Resistance Level
  • APYX $1.57
  • LPCN $5.40
  • Average True Range (ATR)
  • APYX 0.13
  • LPCN 0.56
  • MACD
  • APYX 0.02
  • LPCN -0.10
  • Stochastic Oscillator
  • APYX 50.55
  • LPCN 36.10

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: